Fiduciary Trust Co decreased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 1.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 44,478 shares of the exchange traded fund’s stock after selling 579 shares during the period. Fiduciary Trust Co’s holdings in SPDR S&P Biotech ETF were worth $4,394,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. Tidemark LLC raised its stake in shares of SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after acquiring an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. bought a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $40,000. ORG Partners LLC bought a new position in shares of SPDR S&P Biotech ETF in the second quarter valued at approximately $40,000. ORG Wealth Partners LLC bought a new position in SPDR S&P Biotech ETF in the 3rd quarter worth approximately $44,000. Finally, Howe & Rusling Inc. bought a new position in SPDR S&P Biotech ETF in the 3rd quarter worth approximately $49,000.
SPDR S&P Biotech ETF Price Performance
XBI stock opened at $100.00 on Friday. The company has a 50 day moving average price of $98.31 and a 200 day moving average price of $96.48. SPDR S&P Biotech ETF has a fifty-two week low of $72.10 and a fifty-two week high of $105.47. The stock has a market capitalization of $7.62 billion, a PE ratio of 11.47 and a beta of 1.11.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- High Flyers: 3 Natural Gas Stocks for March 2022
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- 5 discounted opportunities for dividend growth investors
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Differences Between Momentum Investing and Long Term Investing
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.